Search for cancer therapies could be transformed by innovative technique
the ONA take:
Researchers based at the University of Illinois have now developed a technique to pinpoint novel, medically relevant products produced created by bacteria. Many companies have steered away from natural product discovery due to the difficulties developing new products, but using their new technique, the investigators quickly has success developing a novel product derived from soil bacteria. Soil bacteria has been historically a good source, as it produces antibiotics to repel competitors.
The investigators used genomics to screen the soil bacteria in their search for novel antibiotic products. As the screening takes place, compounds of interest are tagged for review. The tags add mass, allowing the researchers to detect the compounds via mass spectrometry. (The most popular method typically used to identify novel products is bioassay-guided isolation, which has the tendency to produce similar results on repeated trials by "rediscovering" the most active or abundant compounds to the exclusion of the rarer compounds, which go unnoticed.) The sensitivity of mass spectrometry allows for novel products present at lower abundance.
Research results was reported in the journal ACS Chemical Biology.
Search for new cancer therapies could be transformed by innovative technique
In a study reported in ACS Chemical Biology, University of Illinois researchers developed a new technique to quickly uncover novel, medically relevant products produced by bacteria.
Past techniques involved screening more than 10,000 samples to find a novel product, said principal investigator Doug Mitchell, assistant professor of chemistry and Institute for Genomic Biology (IGB) member.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|